Navigation Links
New Prostate Cancer Drug May Hold Promise
Date:4/7/2009

Researchers apply for large-scale testing after 'very promising' early results,,

TUESDAY, April 7 (HealthDay News) -- A new drug with a radically different way of attacking prostate cancer has done well in an initial trial and is ready for larger-scale testing, researchers report.

One standard treatment for the malignancy is to inhibit the activity of androgens, male hormones such as testosterone that help drive tumor growth. Existing anti-androgens try to "shut down the factory" that produces the hormones, but the new drug blocks the receptors for those androgens on the tumor cells, said Dr. Howard I. Scher, chief of the genitourinary oncology service at Memorial Sloan-Kettering Cancer Center in New York City and co-author of a report to be published online by the journal Science.

"There is a lot of interest in the drug, because the preliminary results are very promising," Scher said.

The report in the journal describes the results of the treatment of 30 men with advanced prostate cancer that was not responding to conventional anti-androgen therapy. After treatment with the drug, there were "sustained declines" in blood levels of prostate specific antigen, a biomarker of tumor growth, in 13 of the 30, or 43 percent, which the report called a "promising" result.

The researchers now have data on 114 men given the drug, Scher said. "It showed not only declines in PSA but also regression of the tumor on scans and also that circulating tumor cell counts, another measure of treatment, converted from unfavorable to favorable in a considerable percentage of patients," he said.

Based on those results, Scher said, an application for a large-scale trial has been submitted to the U.S. Food and Drug Administration by Medivation Inc., a California-based biopharmaceutical company that has licensed the drug, now called MDV3100. The hope is that the trial will lead to FDA approval of the drug for clinica
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Red wine compound shown to prevent prostate cancer
7. Barbershop Talks Cut Black Mens Prostate Cancer Risk
8. Generic prostate drug helps find high-risk cancers early
9. Finasteride unlikely to induce high grade prostate cancers
10. Shrinkage of prostate led to overestimation of cancer risk in trial
11. Prostate Cancer Awareness Week to Screen Thousands
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Prostate Cancer Drug May Hold Promise
(Date:11/23/2014)... More than two dozen new claims were ... involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ), as well as ... , A Case List updated on November 17th ... 2 diabetes medications referred to as incretin mimetics have ... District of California, where a federal proceeding continues to ...
(Date:11/23/2014)... 2014 The FDA is Watching: , ... On-Demand Webinar**, Dec. 11, 2014 ? Any Time at ... focus on promotional activities is no longer limited to ... looking at websites, Twitter, journal articles, TV appearances, Facebook ... Dec. 11, for On-Demand access to Timothy Ayers and ...
(Date:11/23/2014)... 23, 2014 Today Zane Benefits, ... small businesses, announced their new on demand webinar ... Employer-Provided Health Insurance. , According to ... financial risk facing most American families. It is ... and large, when it comes to recruiting and ...
(Date:11/22/2014)... PrettyTailor , an outstanding dress company, ... promotion. Customers can buy new dresses at its online ... its website. , As a matter of fact, PrettyTailor ... mainly provides four types of wedding outfits, including bridesmaid ... dresses. It also provides a variety of occasion dresses, ...
(Date:11/22/2014)... BambooFlooringChina.com is a famous brand in ... its new collection of bamboo mats ; the new ... off. , According to the sales manager of ... it a highly renewable resource. Their bamboo mats are 100% ... which comes from natural bamboo with caramel bamboo strips. ...
Breaking Medicine News(10 mins):Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2
... OAK BROOK, Ill. July 31, 2008 A ... (BE) with high-grade dysplasia (HGD) showed that in 92 patients ... follow-up biopsy session, 90.2 percent were free of HGD at ... to report on the use of circumferential ablation for BE ...
... conceived this way have poorer outcomes, but procedure not ... July 31 (HealthDay News) -- The increased risk of ... fertilization (AF) may be due to causes of infertility ... In general, single babies conceived using AF have worse ...
... July 31 Affiliated Computer Services,Inc. (NYSE: ... totaling $100,million, with UMass Memorial Health Care, Inc., ... services. The contract will extend an existing six-year ... ACS will provide a cost-effective,method of expanding UMass ...
... This Approval Creates New Growth Opportunities for the ... FY2008 Make Good Target of $5.6 million, ... Inc. (OTC Bulletin Board: TYNP), a manufacturer and,supplier ... China, today announced that it has received approval ...
... to Gift MedeFile-Light to National ... ... 31 MedeFile,International, Inc. (OTC Bulletin Board: MDFI), a company ... and their families, today announced that it has teamed with,Direct ...
... EATONTOWN, N.J., July 31 Osteotech, Inc.,(Nasdaq: OSTE ), ... healing, reported today that net income for the three months,ended ... per share,compared to net income of $.9 million, or $.05 ... for the three months ended June 30,2008 increased 4% to ...
Cached Medicine News:Health News:Endoscopic circumferential ablation promising for Barrett's esophagus with high-grade dysplasia 2Health News:Endoscopic circumferential ablation promising for Barrett's esophagus with high-grade dysplasia 3Health News:Endoscopic circumferential ablation promising for Barrett's esophagus with high-grade dysplasia 4Health News:Assisted Fertilization Risks May Be Due to Infertility 2Health News:ACS Signs Five-Year, $100 Million Deal to Provide Technology Services to UMass Memorial Health Care, Inc. 2Health News:ACS Signs Five-Year, $100 Million Deal to Provide Technology Services to UMass Memorial Health Care, Inc. 3Health News:Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Simvastatin Tablets 2Health News:Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Simvastatin Tablets 3Health News:Direct Technology Innovations Lauds MedeFile Solution as 'Breakthrough' in Personal Medical Records Management 2Health News:Direct Technology Innovations Lauds MedeFile Solution as 'Breakthrough' in Personal Medical Records Management 3Health News:Direct Technology Innovations Lauds MedeFile Solution as 'Breakthrough' in Personal Medical Records Management 4Health News:Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million 2Health News:Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million 3Health News:Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million 4Health News:Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million 5
(Date:11/22/2014)... 21 de noviembre de 2014  BioClinica®, Inc., ... externalizados y tecnologías eClinical, ha indicado un aumento ... inteligente, para el seguimiento basado en el riesgo ... el concepto del seguimiento basado en el riesgo ... visitas de seguimiento o cambio de los métodos ...
(Date:11/22/2014)... Statistics released from a number of organizations show that ... holidays, beginning with Thanksgiving eve, which is now termed ... data, highlighted in an Infographic released by ... annual Sober Days for the Holidays public awareness ... increased rates of DUI injuries and deaths during the ...
(Date:11/22/2014)... Nov. 21, 2014  Particle Sciences, Inc (PSI), ... developed and manufactured a new innovative vaginal ring ... and Development arm of Exeltis Pharmaceuticals.  According to ... Management at Particle Sciences, "This vaginal ring was ... material sciences and modeling expertise.  We are thrilled ...
Breaking Medicine Technology:El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3Alarming Stats Show Holiday Drinking an Issue for Many 2Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2
... CHARLOTTE, N.C., Oct. 29 MedCath Corporation (Nasdaq: MDTH ) will host a ... its fourth quarter ended September 30, 2009. The company will issue a press release ... What: Fourth Quarter Earnings Conference Call, ... How: Dial-in conference call, ...
... BOSTON, Oct. 29 Solos Endoscopy, Inc. (Pink Sheets: ... received purchase orders for its MammoView(TM) line of surgical ... Center, San Diego California. UCSD Medical Center is highly ... amount of healthcare in San Diego. UCSD Medical Center ...
Cached Medicine Technology:MedCath Corporation to Hold Conference Call on Fourth Quarter Results 2Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line 2
This fume hood features a one-piece shell molded of polyethylene with a clear acrylic panel that slides on inside tracks. It can be set in an open, closed or intermediate position....
These handy dispensers save space and organize gloves in labs and next to hand washers. Clear acrylic. Many other sizes and custom configurations available....
... Microtome is ideal for sectioning of specimens in ... Specimen rise is automatic and accurate with section ... increments of 2 microns. Will accommodate MNL ... Vibratomes Freezing Stages , ...
... Gold Package is the ultimate ... package includes the Vibratome 3000 ... starter package accessory kit, additional ... mounts 1/2" head, rotating stage, ...
Medicine Products: